International Society for Heart & Lung Transplantation and XDx Announce Results of IMAGE Study
April 22nd, 2010

XDx Announces Plenary Session Presentation of IMAGE Trial Results
April 16th, 2010

XDx Appoints New Chief Financial Officer
January 5th, 2010

XDx to Present at the J.P. Morgan 28th Annual Healthcare Conference
January 5th, 2010

XDx to Present at the Piper Jaffray 21st Annual Healthcare Conference
November 25th, 2009

XDx to Present at the JMP Securities Healthcare Focus Conference
September 30th, 2009

XDx to Present at the Thomas Weisel 2009 Healthcare Conference
September 3rd, 2009

XDx Completes Series G Financing
August 5th, 2009

XDx to Present at the Future Leaders in the Biotech Industry Conference
March 26, 2009

XDx Selected to Present at InsideVenture’s Debut Investor Conference
March 23, 2009

XDx and Bristol-Myers Squibb Enter into Pharmacogenomics Collaboration
January 9, 2009

XDx to Present at the 2008 In Vitro Diagnostic Regulatory and Reimbursement Conference
November, 2008

XDx to Present at the Third Annual JMP Securities Healthcare Focus Conference
October, 2008

FDA Clears Test to Help Doctors Manage Heart Transplant Patients
August, 2008

XDx’s AlloMap^® Gene Expression Test Cleared by U.S. Food and Drug Administration
August, 2008

Personalized Medicine Coalition Announces Two New Board Members
July, 2008

XDx Appoints Industry Veteran Jay M. Moyes as Chief Financial Officer
May, 2008

XDx Files Reexamination Request for Source MDx Patent
February, 2008

XDx, Inc. Files Registration Statement for Proposed Initial Public Offering
October, 2007

XDx Sponsors Heart Transplant Recipient and Professional Golfer Erik Compton at The Ultimate Game at Wynn
June, 2007

XDx Presents Recent Success with AlloMap Molecular Expression Testing to International Transplantation Community
April, 2007

XDx and University of Minnesota Establish Lupus Collaboration
February, 2007

XDx to Present at BIO CEO & Investor Conference
February, 2007

Independent Clinical Data Confirms Accuracy of Gene Expression Test for Heart Transplant Patients
January, 2007

XDx to Present at 2007 JP Morgan Healthcare Conference
January, 2007

XDx Announces Appointment of Dr. Mitchell Nelles to Vice President R&D, Technical Operations
January, 2007

Gene Expression Test from XDx Now Indicated for Earlier Use and Prediction of Acute Cellular Rejection
October, 2006

XDx Announces Appointment of Dr. James Yee as Chief Medical Officer
August, 2006

XDx Completes $26.5 Million Private Equity Financing
January, 2006

XDx Named 2006 Technology Pioneer by World Economic Forum
December, 2005

XDx Announces Appointment of Vikram Jog as CFO
May, 2005

XDx Launches Noninvasive Test to Enable Better Management of Heart Transplant Patients
April, 2005